Colgate-Palmolive Company (CL)
| Market Cap | 67.47B |
| Revenue (ttm) | 16.16B |
| Net Income (ttm) | 2.69B |
| Shares Out | 857.40M |
| EPS (ttm) | 3.13 |
| PE Ratio | 25.22 |
| Forward PE | 25.19 |
| Dividend | $1.76 |
| Dividend Yield | 2.23% |
| Trading Day | January 26 |
| Last Price | $78.95 |
| Previous Close | $78.61 |
| Change ($) | 0.34 |
| Change (%) | 0.43% |
| Day's Open | 78.87 |
| Day's Range | 77.93 - 79.09 |
| Day's Volume | 2,695,998 |
| 52-Week Range | 58.53 - 85.78 |
Colgate-Palmolive To Offer Almost 5% Dividend Growth This Year
Colgate-Palmolive is a Dividend Champion with 57 consecutive years of dividend growth. Shares currently yield 2.25%. Colgate-Palmolive is a SWAN business that should continue churning out high...
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
These companies offer stability no matter how turbulent things get.
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2020 fourth quarter and year-end earnings conference call on Friday, January 29, 2021, at 8:30...
In trading on Tuesday, shares of Colgate-Palmolive entered into oversold territory, hitting an RSI reading of 29.3
The NFL playoffs have started. With many cities in lockdown, these seven consumer stocks to buy could benefit from increased home viewing.
From consumer packaged goods to beverages, there are plenty of big names that could benefit from the industry's rapid growth.
NEW YORK--(BUSINESS WIRE)--The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.44 per common share, payable on February 16, 2021, to sh...
NEW YORK--(BUSINESS WIRE)-- #dentalscholarship--Colgate-Palmolive announces $210,000 gift to initiate the Harvard School of Dental Medicine endowed Freeman, Grant, Franklin Scholarship.
Colgate Palmolive stock is up around 20% since the beginning of 2020, and at the current price around $82 per share, we believe that Colgate stock has around 10% potential downside. Why is that?
Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Despite cost and currency-related headwinds, strong product demand and sturdy online show are likely to help Colgate (CL) stay put amid this COVID-19 crisis.
Each one has much more to offer investors than a steadily growing dividend payout.
As the Covid-19 pandemic worsens, the case for dental stocks to buy might not seem too bright. However, this sector is a very broad one, with upside opportunities available right now.
I Replaced A Jumbo CD With This Eclectic Portfolio Of Value-Conscious Dividend-Paying Stocks
Consumers' home isolation trend stemming from the pandemic has been a huge accelerator for the pet industry. Tractor Supply (TSCO), Chewy (CHWY), Colgate (CL) and Spectrum Brands (SPB) look we...
5 Soaps & Cleaning Products Stocks Worth a Look Amid Coronavirus Woes
Colgate-Palmolive Company (CL) Management presents at Morgan Stanley Virtual Global Consumer & Retail Conference (Transcript)
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock?
Coronavirus vaccine or not, this diversified basket is poised to perform.
Colgate (CL) benefits from the increase in demand for personal and home care products due to the pandemic-led increase in hygiene habits.
These companies are not only well established, but they takes their payout's reliable growth seriously.
These companies will allow you to sleep soundly at night while collecting cash.
NEW YORK--(BUSINESS WIRE)-- #covid19--Laboratory studies show that toothpastes containing zinc or stannous and mouthwash formulas with cetylpyridinium chloride (CPC) neutralize the virus that ...
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Group President, Colgate-Latin America, Asia Pacific & Africa-Eurasia, Panagiotis Tsourapas, will participate in a virtual fireside chat ...
NEW YORK--(BUSINESS WIRE)-- #climate--Colgate-Palmolive announces its 2025 Sustainability & Social Impact Strategy, defining key actions & setting measurable targets for 2025 & beyond.
Pfizer's vaccine news announcement is very encouraging, but the coming weeks could still see significant volatility. You can prepare your portfolio for a "dark winter" with resilient Dividend ...
Many investors believe that financial markets react to the news. But it's a bit more nuanced than that.
Regardless of who wins the presidential election, most of us are just ready for the political circus to be over.
On Oct. 30 before the market opened, Colgate-Palmolive Co. (NYSE:CL) reported earnings results for the third quarter of 2020.
Colgate-Palmolive Company (CL) CEO Noel Wallace on Q3 2020 Results - Earnings Call Transcript
Colgate (CL) reports accelerated earnings and sales growth in third-quarter 2020 on strong demand for its products, innovation and positive e-commerce trends.
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 12.86% and 4.60%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the st...
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) announced today the appointment of Stanley J. Sutula, currently Executive Vice President and Chief Financial Officer of Pitney Bo...
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) Net sales increased 5.5%, Organic sales* increased 7.5% GAAP EPS grew 21% to $0.81, Base Business EPS* grew 11% to $0.79 GAAP Gro...
Colgate-Palmolive Co. reported third-quarter net income of $698 million, or 81 cents per share, up from $578 million, or 67 cents per share, last year. Adjusted EPS of 79 cents exceeded the Fa...
In times of economic recession, investors should prioritize dividend safety. Instead of buying stocks with the highest yields, it makes sense to focus on quality, asserts Ben Reynolds, editor ...
Colgate's (CL) Q3 performance is expected to have benefited from strong demand for essential goods, robust e-commerce sales and a booming pet business despite higher costs and currency.
Keeping this in mind, let's analyze whether Colgate-Palmolive Company (NYSE:CL) is a good investment right now by following the lead of some of the best investors in the world and piggybacking...
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes?
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stocks continued yesterday's rally on more stimulus optimism and strong earnings, although Goldman Sachs expressed doubts about the stimulus package. For investors looking to make sense of the...
The true definition of dividend growth investing is quite clear, but I am finding plenty of folks here really do not understand it.
10 Dividend Growth Stocks For October 2020
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2020 third quarter earnings conference call on Friday, October 30, 2020, at 8:30 a.m. ET. The ...
Colgate-Palmolive (CL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is (CL) Outperforming Other Consumer Staples Stocks This Year?
About CL
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. This segment markets and sells its products ... [Read more...]
| Industry Household & Personal Products | Founded 1806 |
| CEO Noel Wallace | Employees 34,300 |
| Stock Exchange NYSE | Ticker Symbol CL |
Financial Performance
In 2019, CL's revenue was $15.69 billion, an increase of 0.96% compared to the previous year's $15.54 billion. Earnings were $2.37 billion, a decrease of -1.38%.
Analyst Forecasts
According to 21 analysts, the average rating for CL stock is "Buy." The 12-month stock price forecast is 84.60, which is an increase of 7.16% from the latest price.